2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-
| Title | Journal |
|---|---|
| Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. | Antimicrobial agents and chemotherapy 20130601 |
| Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities. | International journal of antimicrobial agents 20120601 |
| The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice. | Evidence-based complementary and alternative medicine : eCAM 20100601 |
| Transgenic cardiac-targeted overexpression of human thymidylate kinase. | Laboratory investigation; a journal of technical methods and pathology 20100301 |
| Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance. | Journal of separation science 20090601 |
| Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy. | Journal of medical primatology 20070801 |
| Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. | Antimicrobial agents and chemotherapy 20060801 |
| New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy. | Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20060601 |
| New drugs. | HIV medicine 20050701 |
| SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. | Journal of medical primatology 20050601 |
| In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. | Antimicrobial agents and chemotherapy 20050301 |
| Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans. | Antiviral chemistry & chemotherapy 20050101 |
| New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections. | Current opinion in pharmacology 20041001 |
| Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. | Antimicrobial agents and chemotherapy 20030601 |
| In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. | Antimicrobial agents and chemotherapy 20020601 |
| In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients. | The Journal of antimicrobial chemotherapy 19991101 |
| KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis. | Antimicrobial agents and chemotherapy 19980101 |
| In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp. | Antimicrobial agents and chemotherapy 19980101 |
| High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. | Antimicrobial agents and chemotherapy 19931001 |
| Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents. | Journal of medicinal chemistry 19930903 |
| Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. | Proceedings of the National Academy of Sciences of the United States of America 19930615 |
| Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. | Antimicrobial agents and chemotherapy 19930401 |
| The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. | Antimicrobial agents and chemotherapy 19921201 |
| Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. | Antimicrobial agents and chemotherapy 19921101 |
| Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. | Proceedings of the National Academy of Sciences of the United States of America 19911001 |